Clinical trial

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic…

NCT00002811 · Applied Genetics, Industry · Unknown status

Key facts

NCT number NCT00002811
Title T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
Official title A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER CLINICAL STUDY TO TEST THE SAFETY AND EFFICACY OF T4N5 LIPOSOME LOTION ON PATIENTS WITH XERODERMA PIGMENTOSUM IN THE PROTECTION AGAINST ACTINIC KERATOSES
Lead sponsor Applied Genetics, Industry
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Precancerous Condition
Intervention type Drug
Interventions liposomal T4N5 lotion
Enrollment 30
Start date Jul 1, 1996
First posted Sep 2, 2004
Last update posted Nov 6, 2013
Countries Germany, United Kingdom, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies